Breastfeeding and Maternal and Child Cardiometabolic Outcomes 10-14 Years after Delivery

Yiwen Cui1, Kartik K Venkatesh2, Anna Palatnik3,4

  • 1Orlando Health Women's Institute Center for Fetal Care, Orlando, Florida, USA.

Insights

Breastfeeding is linked to lower childhood risks of glucose metabolism disorders and adiposity. While maternal glucose metabolism risks were unchanged, breastfeeding reduced maternal dyslipidemia and offspring adiposity.

Area of Science:

  • Cardiovascular science
  • Endocrinology
  • Public health

Background:

  • Breastfeeding offers long-term cardiometabolic benefits, yet many outcomes require further study.
  • Understanding these benefits is crucial for maternal and child health.
  • Previous research highlights some benefits, but long-term effects need more investigation.

Purpose of the Study:

  • To investigate the association between breastfeeding and maternal and child cardiometabolic health 10-14 years post-delivery.
  • To analyze risks of glucose metabolism disorders, hypertension, and dyslipidemia.
  • To assess child adiposity in relation to breastfeeding status.

Main Methods:

  • Secondary analysis of the prospective Hyperglycemia and Adverse Pregnancy Outcome Follow-Up Study (2013-2016).
  • Exposure: any breastfeeding. Outcomes: maternal/child glucose metabolism disorders, hypertension, dyslipidemia, and child adiposity.
  • Multivariate logistic regression analyzed associations between breastfeeding and cardiometabolic outcomes.

Main Results:

  • Breastfeeding was associated with a lower risk of childhood glucose metabolism disorders (aRR: 0.76).
  • Mothers who breastfed showed lower rates of dyslipidemia (aRR: 0.88), and offspring had lower adiposity (aRR: 0.82).
  • In mothers with gestational diabetes, breastfeeding reduced child hypertension (aRR: 0.66) and adiposity (aRR: 0.67).

Conclusions:

  • Breastfeeding is associated with reduced cardiometabolic risks in offspring, including glucose metabolism disorders and adiposity.
  • Breastfeeding also benefits maternal health by reducing dyslipidemia risk.
  • Targeted interventions for mothers with gestational diabetes may enhance these protective effects.